[1]
R. G. Hussein and M. Q. Al-Atrakji, “Impact of Infliximab Biosimilar (Ixifi®) Trough Levels on Disease Activity and Inflammatory Markers in Iraqi Rheumatoid Arthritis Patients”, Al-Rafidain J Med Sci, vol. 7, no. 1(Special), pp. S36–40, Sep. 2024.